Eden Research (LON:EDEN) Shares Up 26.5% – Here’s What Happened

Eden Research plc (LON:EDEN) shot up 26.5% during mid-day trading on Wednesday . The stock traded as high as GBX 3.48 ($0.05) and last traded at GBX 3.48 ($0.05). 778,726 shares changed hands during mid-day trading, an increase of 16% from the average session volume of 670,749 shares. The stock had previously closed at GBX 2.75 ($0.04).

Eden Research Stock Up 2.6%

The company has a market cap of £21.33 million, a P/E ratio of -14.01 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm’s 50 day moving average price is GBX 2.82 and its 200-day moving average price is GBX 3.44.

Eden Research (LON:EDEN) last released its quarterly earnings data on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) earnings per share for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. As a group, equities research analysts expect that Eden Research plc will post -66.0000038 EPS for the current year.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Sean M. Smith bought 426,986 shares of Eden Research stock in a transaction dated Tuesday, April 1st. The stock was bought at an average price of GBX 234 ($3.11) per share, with a total value of £999,147.24 ($1,329,714.19). Also, insider Alexander John Abrey bought 167,947 shares of Eden Research stock in a transaction dated Tuesday, March 4th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,705.36). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.